Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 1976CancerOpen Access

Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

EMEugene M. McKelveyThe University of Texas MD Anderson Cancer CenterJGJeffrey A. GottliebNational Cancer InstituteHWHenry E. WilsonColumbus Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

McKelvey et al. (1976) studied this question.

synapsesocial.com/papers/6a1d1dbbba65f5ee325dd30ehttps://doi.org/10.1002/1097-0142(197610)38:4<1484::aid-cncr2820380407>3.0.co;2-i
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Combination Chemotherapy of Lymphomas Other Than Hodgkin's Disease1974 · 55 citations
  2. 2Long-term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy1975 · 95 citations
  3. 3Potential for Prolonged Disease-free Survival Following Combination Chemotherapy of Non-Hodgkin’s Lymphoma1974 · 163 citations
  4. 4Non-Hodgkin's lymphomas. II. Single agent chemotherapy1972 · 151 citations
  5. 5A generalized Wilcoxon test for comparing arbitrarily singly-censored samples1965 · 3,344 citations